You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NX-5948

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • NX-5948
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Ulcerative Colitis Trial in Ukraine, United States (NX-13 250mg IR, NX-13 500mg IR, NX-13 500mg MR)

Completed
  • Ulcerative Colitis
  • NX-13 250mg IR
  • +3 more
  • Huntsville, Alabama
  • +30 more
Jan 6, 2023

Opioid Use Disorder Trial in Vancouver (Buprenorphine/naloxone, Hydromorphone)

Recruiting
  • Opioid Use Disorder
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Oct 5, 2022

Solid Tumor Trial (ABSK121-NX)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Nov 21, 2022

Platinum-resistant Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in New Brunswick, Buffalo, Pittsburgh (Drug Product

Active, not recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Drug Product De-TIL-0255
  • New Brunswick, New Jersey
  • +3 more
Nov 15, 2022

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting
  • Ovarian Cancer, Epithelial
  • +14 more
  • Sutton, Surrey, United Kingdom
  • +6 more
Jul 22, 2022

EGFR Mutation-Related Tumors Trial (NX-019)

Not yet recruiting
  • EGFR Mutation-Related Tumors
  • (no location specified)
Aug 22, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Opioid Use, Opioid Use Disorder, Risk Reduction Trial in Durham, Greensboro (Suboxone, Truvada, Mavyret)

Active, not recruiting
  • Opioid Use
  • +4 more
  • Durham, North Carolina
  • +1 more
Jan 19, 2023

Low Risk Differentiated Thyroid Cancer Trial in Villejuif (rhTSH stimulation, I131, Follow up)

Active, not recruiting
  • Low Risk Differentiated Thyroid Cancer
  • rhTSH stimulation
  • +2 more
  • Villejuif, Val De Marne, France
    Institut Gustave Roussy
Dec 7, 2021

Coronary Artery Disease Trial in Antwerp, Genk, Sao Paulo (DESolve Cx drug eluting coronary scaffold system)

Completed
Has Results
  • Coronary Artery Disease
  • DESolve Cx drug eluting coronary scaffold system
  • Antwerp, Belgium
  • +2 more
Jul 13, 2021

Ulcerative Colitis Trial (NX-13 250mg, NX-13 750mg, NX-13 Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • NX-13 250mg
  • +2 more
  • (no location specified)
Mar 28, 2023

Opioid-use Disorder, Cocaine Use Disorder Trial in Philadelphia (Cariprazine 1.5 MG, Placebo)

Recruiting
  • Opioid-use Disorder
  • Cocaine Use Disorder
  • Cariprazine 1.5 MG
  • Placebo
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 8, 2022

Ulcerative Colitis Trial in Melbourne (NX-13 250 mg, Placebo)

Completed
  • Ulcerative Colitis
  • NX-13 250 mg
  • Placebo
  • Melbourne, Australia
    Nucleus Network
Mar 8, 2022

Breast Cancer Trial (TAC, NX)

Completed
  • Breast Cancer
  • (no location specified)
Feb 2, 2021

Opioid Use Disorder Trial in United States (Extended-Release Naltrexone, Buprenorphine-Naloxone)

Completed
Has Results
  • Opioid Use Disorder
  • Tarzana, California
  • +7 more
Jul 30, 2020

Using Pulsatile Near Infrared Spectroscopy in Neonates

Recruiting
  • Neonatal Disease
  • No intervention
  • Graz, Styria, Austria
    Division Neonatology, Dep. Pediatrics
May 31, 2023

Breast Cancer Trial in Shanghai (Capecitabine, Vinorelbine)

Unknown status
  • Breast Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital/ Institute, Fudan University
Mar 11, 2020

Following Discharge From Detoxification and Short Term

Completed
Has Results
  • Opioid Use Disorder
  • Treatment As Usual
  • Tarzana, California
  • +4 more
Mar 17, 2020

Opiate Substitution Treatment Trial in Sacramento (Standard Medical Management (SMM))

Completed
  • Opiate Substitution Treatment
  • Standard Medical Management (SMM)
  • Sacramento, California
    Kaiser Sacramento Chemical Dependency Recovery Program
Sep 25, 2019

Coronary Artery Disease Trial in Worldwide (DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System)

Completed
  • Coronary Artery Disease
  • DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System
  • Antwerp, Belgium
  • +12 more
Apr 6, 2020

Opioid Use Disorders Trial in United States (CAM2038 SC injection, SL BPN/NX tabs, SC injections)

Completed
Has Results
  • Opioid Use Disorders
  • CAM2038 SC injection
  • +3 more
  • Birmingham, Alabama
  • +35 more
Aug 6, 2019

Susceptibility, Genetic, Chemo Effect Trial in Tianjin (DT group, ET group, NX group)

Unknown status
  • Susceptibility, Genetic
  • Chemotherapy Effect
  • DT group
  • +2 more
  • Tianjin, China
    Jin Zhang
Nov 27, 2017

Benign Prostatic Hyperplasia, BPH, Lower Urinary Tract Symptoms (LUTS) Trial in United States (NX-1207)

Completed
  • Benign Prostatic Hyperplasia
  • +3 more
  • Laguna Beach, California
  • +16 more
Mar 9, 2017

Opioid Dependence Trial in United States (BEMA Buprenorphine NX films)

Completed
Has Results
  • Opioid Dependence
  • BEMA Buprenorphine NX films
  • Birmingham, Alabama
  • +9 more
Feb 13, 2017